Analysis Group, Inc.   Report issue

For profit Phase 4
Founded: Boston MA United States (1981)

Organization Overview

First Clinical Trial
2018
NCT03405194
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Analysis Group, Inc.